J Chad Brenner Selected Research

J Chad Brenner Research Topics

Disease

44	Neoplasms (Cancer) 02/2024 - 05/2008
34	Squamous Cell Carcinoma of Head and Neck 02/2024 - 12/2013
10	Head and Neck Neoplasms (Head and Neck Cancer) 01/2023 - 12/2013
8	Prostatic Neoplasms (Prostate Cancer) 09/2014 - 03/2011
4	Laryngeal Neoplasms (Laryngeal Cancer) 10/2020 - 03/2016
4	Breast Neoplasms (Breast Cancer) 10/2020 - 10/2013
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022 - 02/2019
3	Carcinogenesis 01/2021 - 08/2011
3	Disease Progression 01/2019 - 07/2011
3	Ewing Sarcoma (Sarcoma, Ewing) 09/2014 - 04/2012
2	Oropharyngeal Neoplasms 01/2023 - 01/2023
2	Neoplasm Metastasis (Metastasis) 04/2016 - 12/2008
1	Hypoxia (Hypoxemia) 01/2023
1	Chordoma 02/2022
1	Circulating Neoplastic Cells 01/2022
1	Bites and Stings (Sting) 01/2020
1	Hypocalcemia 08/2019
1	Mucoepidermoid Carcinoma 01/2019
1	Small Cell Carcinoma 11/2018
1	Carcinoma in Situ 11/2018
1	Malignant Teratocarcinosarcoma 08/2017
1	Urinary Bladder Neoplasms (Bladder Cancer) 03/2015
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2013
1	Lymphoma (Lymphomas) 06/2013
1	Leukemia 06/2013
1	Carcinoma (Carcinomatosis) 06/2013
1	Synovial Sarcoma (Synovioma) 06/2013

Drug/Important Bio-Agent (IBA)

12	Biomarkers (Surrogate Marker)IBA 10/2023 - 03/2011
6	Circulating Tumor DNAIBA 02/2024 - 01/2019
5	DNA (Deoxyribonucleic Acid)IBA 02/2024 - 03/2015
5	RNA (Ribonucleic Acid)IBA 01/2023 - 07/2011
4	ParaffinIBA 11/2018 - 03/2015
3	Proteins (Proteins, Gene)FDA Link 01/2016 - 08/2011
2	Cetuximab (Erbitux)FDA Link 12/2023 - 01/2023
2	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 11/2023 - 01/2016
2	LigandsIBA 11/2023 - 01/2021
2	Interferon Type IIBA 01/2021 - 01/2020
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2019 - 01/2016
2	Formaldehyde (Formol)FDA Link 01/2017 - 03/2015
2	LGK974IBA 04/2016 - 12/2013
2	Transcription Factors (Transcription Factor)IBA 09/2014 - 12/2012
2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 10/2013 - 05/2011
2	Androgen Receptors (Androgen Receptor)IBA 12/2012 - 07/2012
1	Phosphotransferases (Kinase)IBA 12/2023
1	GlycosyltransferasesIBA 11/2023
1	InterferonsIBA 01/2023
1	Farnesyltranstransferase (Farnesyltransferase)IBA 01/2023
1	Sirtuin 1IBA 10/2022
1	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 02/2022
1	Tumor Biomarkers (Tumor Markers)IBA 01/2022
1	OxidesIBA 01/2022
1	TNF Receptor-Associated Factor 2 (TRAF2)IBA 10/2021
1	Toll-Like Receptor 2IBA 09/2021
1	Axitinib (AG 013736)IBA 01/2021
1	CytokinesIBA 01/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021
1	Interferon alpha-beta Receptor (Receptor, Interferon alpha beta)IBA 01/2021
1	palbociclibIBA 10/2020
1	Carboplatin (JM8)FDA LinkGeneric 10/2020
1	ErbB Receptors (EGF Receptor)IBA 01/2019
1	MI-773IBA 01/2019
1	CateninsIBA 08/2017
1	Intergenic DNA (Junk DNA)IBA 10/2016
1	NVP-BKM120IBA 01/2016
1	Protein Isoforms (Isoforms)IBA 01/2016
1	Proto-Oncogene Proteins c-etsIBA 10/2013
1	EPR3864IBA 06/2013
1	Hormones (Hormone)IBA 12/2012
1	Histones (Histone)IBA 07/2012
1	ChromatinIBA 07/2012
1	AndrogensIBA 07/2012
1	EWS-FLI fusion proteinIBA 04/2012
1	MicroRNAs (MicroRNA)IBA 08/2011
1	Long Noncoding RNAIBA 07/2011
1	Phosphatidylinositols (Phosphatidylinositol)IBA 03/2011
1	Enhancer of Zeste Homolog 2 ProteinIBA 12/2008
1	Histone MethyltransferasesIBA 12/2008
1	AntioxidantsIBA 05/2008
1	Cysteine (L-Cysteine)FDA Link 05/2008
1	Cisplatin (Platino)FDA LinkGeneric 05/2008
1	GossypolIBA 05/2008
1	Coloring Agents (Dyes)IBA 05/2008

Therapy/Procedure

23	Therapeutics 11/2023 - 01/2015
9	Precision Medicine 01/2021 - 01/2015
8	Laryngectomy 01/2022 - 03/2016
6	Immunotherapy 09/2021 - 01/2019
4	Radiotherapy 01/2023 - 12/2017
2	Aftercare (After-Treatment) 01/2023 - 01/2016
2	Chemoradiotherapy 01/2023 - 12/2017
2	Castration 12/2012 - 07/2012
1	Induction Chemotherapy 01/2022
1	Tracheostomy 01/2017
1	Neck Dissection (Radical Neck Dissection) 03/2016
1	Genomic Medicine 01/2016